174 related articles for article (PubMed ID: 31118711)
1. Direct use of eazyplex
Fiori B; D'Inzeo T; Posteraro B; Menchinelli G; Liotti FM; De Angelis G; De Maio F; Fantoni M; Murri R; Scoppettuolo G; Ventura G; Tumbarello M; Pennestrì F; Taccari F; Sanguinetti M; Spanu T
Infect Drug Resist; 2019; 12():1055-1062. PubMed ID: 31118711
[No Abstract] [Full Text] [Related]
2. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
[TBL] [Abstract][Full Text] [Related]
4. The Evaluation of Eazyplex
Sękowska A; Bogiel T
Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203741
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Molecular Characterization of Extended Spectrum β-Lactamase and Carbapenemase-Producing
Seman A; Mihret A; Sebre S; Awoke T; Yeshitela B; Yitayew B; Aseffa A; Asrat D; Abebe T
Infect Drug Resist; 2022; 15():1367-1382. PubMed ID: 35378892
[TBL] [Abstract][Full Text] [Related]
7. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
8. Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae.
Pournaras S; Poulou A; Voulgari E; Vrioni G; Kristo I; Tsakris A
J Antimicrob Chemother; 2010 Aug; 65(8):1604-7. PubMed ID: 20522444
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a DNA microarray for the rapid detection of extended-spectrum β-lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM).
Cuzon G; Naas T; Bogaerts P; Glupczynski Y; Nordmann P
J Antimicrob Chemother; 2012 Aug; 67(8):1865-9. PubMed ID: 22604450
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Characteristics of Patients with Bloodstream Infections Caused by KPC and NDM Co-Producing Carbapenem-Resistant
Li J; Wu W; Wu M; Zhou Z; Wang J; Qiu M; Xu L; Ren J; Wu X
Infect Drug Resist; 2024; 17():1685-1697. PubMed ID: 38711471
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
Superti SV; Augusti G; Zavascki AP
Rev Inst Med Trop Sao Paulo; 2009; 51(4):211-6. PubMed ID: 19739001
[TBL] [Abstract][Full Text] [Related]
12. Drug Susceptibility and Molecular Epidemiology of
Xiao S; Chen T; Wang H; Zeng Q; Chen Q; Yang Z; Han L; Chen E
Front Med (Lausanne); 2021; 8():754944. PubMed ID: 34722591
[No Abstract] [Full Text] [Related]
13. KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan.
Chen YT; Lin JC; Fung CP; Lu PL; Chuang YC; Wu TL; Siu LK
J Antimicrob Chemother; 2014 Mar; 69(3):628-31. PubMed ID: 24123430
[TBL] [Abstract][Full Text] [Related]
14. Emergence and Comparative Genomics Analysis of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Carrying
Feng C; Wen P; Xu H; Chi X; Li S; Yu X; Lin X; Wu S; Zheng B
mSphere; 2019 Nov; 4(6):. PubMed ID: 31748247
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Peirano G; Seki LM; Val Passos VL; Pinto MC; Guerra LR; Asensi MD
J Antimicrob Chemother; 2009 Feb; 63(2):265-8. PubMed ID: 19028717
[TBL] [Abstract][Full Text] [Related]
16. Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States.
Mendes RE; Jones RN; Woosley LN; Cattoir V; Castanheira M
Open Forum Infect Dis; 2019 Mar; 6(Suppl 1):S69-S78. PubMed ID: 30895217
[TBL] [Abstract][Full Text] [Related]
17. Genetic Diversity of Carbapenem-Resistant
Miao M; Wen H; Xu P; Niu S; Lv J; Xie X; Mediavilla JR; Tang YW; Kreiswirth BN; Zhang X; Zhang H; Du H; Chen L
Front Microbiol; 2018; 9():3341. PubMed ID: 30697205
[TBL] [Abstract][Full Text] [Related]
18. Detection of carbapenem-resistant Klebsiella pneumoniae strains harboring carbapenemase, beta-lactamase and quinolone resistance genes in intensive care unit patients.
Unlu O; Demirci M
GMS Hyg Infect Control; 2020; 15():Doc31. PubMed ID: 33299744
[No Abstract] [Full Text] [Related]
19. First Report of Klebsiella pneumoniae-Carbapenemase-3-Producing Escherichia coli ST479 in Poland.
Ojdana D; Sacha P; Olszańska D; Majewski P; Wieczorek P; Jaworowska J; Sieńko A; Jurczak A; Tryniszewska E
Biomed Res Int; 2015; 2015():256028. PubMed ID: 26339599
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
